>>Signaling Pathways>> DNA Damage/DNA Repair>> DNA Alkylator/Crosslinker>>PR-104A

PR-104A (Synonyms: SN 27858)

Catalog No.GC62490

PR-104A(SN 27858)는 인산염 전구약물 PR-104의 알코올 대사 산물입니다. PR-104A는 저산소 선택적 DNA 가교제/DNA 손상제 및 세포독소입니다. 항종양 활성. PR-104A는 1-전자 NADPH:사이토크롬 P450 산화환원효소에 의해 저산소 상태에서 대사됩니다. PR-104A는 재발성/불응성 T-계통 급성 림프모구성 백혈병(T-ALL) 연구에 사용할 수 있습니다.

Products are for research use only. Not for human use. We do not sell to patients.

PR-104A Chemical Structure

Cas No.: 680199-06-8

Size 가격 재고 수량
5 mg
US$405.00
재고 있음
10 mg
US$720.00
재고 있음
25 mg
US$1,485.00
재고 있음
50 mg
US$2,295.00
재고 있음
100 mg
US$3,420.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

PR-104A (SN 27858) is the alcohol metabolite of phosphate prodrug PR-104. PR-104A is a hypoxia-selective DNA cross-linking agent/DNA-damaging agent and cytotoxin. Antitumor Activity[1]. PR-104A is metabolized under hypoxia by the 1-electron NADPH:cytochrome P450 oxidoreductase. PR-104A can be used for the research of relapsed/refractory T-lineage acute lymphoblastic leukemia (T-ALL)[2].

PR-104A (1-100 uM) shows antiproliferative potency in a panel of 10 human carcinoma cell lines following 4 hours exposures under aerobic and hypoxic conditions with the lowest IC50 (0.51 μM) in H460 non-small cell lung cancer cells and highest (7.3 μM) in PC3 prostate cells[1].

The phosphate ester "pre-prodrug" PR-104 is well tolerated in mice and converted rapidly to the corresponding prodrug PR-104A. H460 xenografts shows significant sensitivity to PR-104 (total dose 3.2 mmol/kg)[1].

[1]. Adam V Patterson, et al. Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104. Clin Cancer Res. 2007 Jul 1;13(13):3922-32.
[2]. Donya Moradi Manesh, et al. AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia. Blood. 2015 Sep 3;126(10):1193-202.

리뷰

Review for PR-104A

Average Rating: 5 ★★★★★ (Based on Reviews and 1 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for PR-104A

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.